Category: Press Release - Page 84 - Psychedelic Alpha

Read more about the article Field Trip Launches Site Management Organization (SMO) Services, Hires Stéphan Côté as Head of Quality

Field Trip Launches Site Management Organization (SMO) Services, Hires Stéphan Côté as Head of Quality

Post published:December 14, 2021
Post category:Press Release

Read more about the article MindMed Appoints Robert Barrow as Chief Executive Officer and Director

MindMed Appoints Robert Barrow as Chief Executive Officer and Director

Post published:December 14, 2021
Post category:Press Release

Read more about the article atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial of RL-007 in Cognitive Impairment Associated with Schizophrenia

atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial of RL-007 in Cognitive Impairment Associated with Schizophrenia

Post published:December 14, 2021
Post category:Press Release

Read more about the article Numinus Wellness Inc. to Commence Trading on the TSX on December 16, 2021

Numinus Wellness Inc. to Commence Trading on the TSX on December 16, 2021

Post published:December 14, 2021
Post category:Press Release

Read more about the article Lobe Sciences Announces That Its Shares Will Trade on the OTCQB(R) Market in the United States

Lobe Sciences Announces That Its Shares Will Trade on the OTCQB(R) Market in the United States

Post published:December 13, 2021
Post category:Press Release

Read more about the article PharmaDrug Announces Addition of Dr. Cindy Hutnik, President of the Canadian Glaucoma Society to Their Scientific Advisory Board to Enhance Ongoing DMT Studies to Treat Glaucoma

PharmaDrug Announces Addition of Dr. Cindy Hutnik, President of the Canadian Glaucoma Society to Their Scientific Advisory Board to Enhance Ongoing DMT Studies to Treat Glaucoma

Post published:December 13, 2021
Post category:Press Release

Read more about the article HAVN Life Successfully Exports Psilocybin from Jamaica Facility into the U.S. for Research Purposes

HAVN Life Successfully Exports Psilocybin from Jamaica Facility into the U.S. for Research Purposes

Post published:December 13, 2021
Post category:Press Release

Read more about the article atai Life Sciences Has Been Selected for Addition to the NASDAQ Biotechnology Index

atai Life Sciences Has Been Selected for Addition to the NASDAQ Biotechnology Index

Post published:December 13, 2021
Post category:Press Release

Read more about the article COMPASS Pathways announces positive outcome of 25mg COMP360 psilocybin therapy as adjunct to SSRI antidepressants in open-label treatment-resistant depression study

COMPASS Pathways announces positive outcome of 25mg COMP360 psilocybin therapy as adjunct to SSRI antidepressants in open-label treatment-resistant depression study

Post published:December 13, 2021
Post category:Press Release

Read more about the article Mydecine Secures Financing and Provides Company Update on Clinical Trials, Drug Development and Technology Initiatives

Mydecine Secures Financing and Provides Company Update on Clinical Trials, Drug Development and Technology Initiatives

Post published:December 9, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.